PARMEET SIDHU: Open Payments
NPI 1477025641 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,520 in 49 payments from 12 companies in 2025. Trend: 2023 $131 · 2024 $129 · 2025 $1,520
Food & beverage: $1,425Education: $95
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 15 | $352 |
| GENZYME CORPORATION | 8 | $334 |
| Arcutis Biotherapeutics, Inc. | 7 | $254 |
| Janssen Biotech, Inc. | 5 | $171 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| UCB, Inc. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| Lilly USA, LLC | 2 | $44 |
| Verrica Pharmaceuticals Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $30 |
Products named: DUPIXENT, OPZELURA, TREMFYA, Zoryve, Bimzelx, COSENTYX, TALTZ, YCANTH.
Industry payments across CA — which companies pay providers there.
